학술논문
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
Document Type
Article
Author
Source
In Lancet Neurology 2011 10(5):415-423
Subject
Language
ISSN
1474-4422